Evidence map›Paper›PMID 37914893›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making.

Qiang Luo, Jonathan W Kanen, Andrea Bari, Nikolina Skandali, Christelle Langley, Gitte Moos Knudsen, Johan Alsiö, Benjamin U Phillips, Barbara J Sahakian, Rudolf N Cardinal and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Striatal Serotonin Release Signals Reward Value.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Qiang Luo *National Clinical Research Center for Aging and Medicine at Huashan Hospital, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science and Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 200433, P. R. China. qluo@fudan.edu.cn.
Jonathan W Kanen *Department of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK.ORCID http://orcid.org/0000-0002-4095-5405
Andrea BariAelis Farma, 33077, Bordeaux, France.
Nikolina SkandaliDepartment of Psychiatry, University of Cambridge, Cambridge, CB2 0SZ, UK.
Christelle LangleyBehavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, CB2 3EB, UK.ORCID http://orcid.org/0000-0001-5061-2820
Gitte Moos KnudsenNeurobiology Research Unit, the Neuroscience Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1508-6866
Johan AlsiöDepartment of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK.
Benjamin U PhillipsDepartment of Psychology, University of Cambridge, Cambridge, CB2 3EB, UK.
Barbara J SahakianNational Clinical Research Center for Aging and Medicine at Huashan Hospital, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science and Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 200433, P. R. China.ORCID http://orcid.org/0000-0001-7352-1745
Rudolf N CardinalDepartment of Psychiatry, University of Cambridge, Cambridge, CB2 0SZ, UK.ORCID http://orcid.org/0000-0002-8751-5167
Trevor W RobbinsNational Clinical Research Center for Aging and Medicine at Huashan Hospital, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science and Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, 200433, P. R. China. twr2@cam.ac.uk.ORCID http://orcid.org/0000-0003-0642-5977
University of Cambridge · GBUniversity of Copenhagen · DK

Funding

Training the Next Generation of Psychiatrists-Scientists for Translational ResearchR25MH129256 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANTONIA S NEW, Maria De Las Mercedes Perez Rodriguez · 2023 to 2026
$831k
NIMH NIH HHS R25 MH129256Wellcome Trust
6 · The paper itself

Abstract

Serotonin is critical for adapting behavior flexibly to meet changing environmental demands. Cognitive flexibility is important for successful attainment of goals, as well as for social interactions, and is frequently impaired in neuropsychiatric disorders, including obsessive-compulsive disorder. However, a unifying mechanistic framework accounting for the role of serotonin in behavioral flexibility has remained elusive. Here, we demonstrate common effects of manipulating serotonin function across two species (rats and humans) on latent processes supporting choice behavior during probabilistic reversal learning, using computational modelling. The findings support a role of serotonin in behavioral flexibility and plasticity, indicated, respectively, by increases or decreases in choice repetition ('stickiness') or reinforcement learning rates following manipulations intended to increase or decrease serotonin function. More specifically, the rate at which expected value increased following reward and decreased following punishment (reward and punishment 'learning rates') was greatest after sub-chronic administration of the selective serotonin reuptake inhibitor (SSRI) citalopram (5 mg/kg for 7 days followed by 10 mg/kg twice a day for 5 days) in rats. Conversely, humans given a single dose of an SSRI (20 mg escitalopram), which can decrease post-synaptic serotonin signalling, and rats that received the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT), which destroys forebrain serotonergic neurons, exhibited decreased reward learning rates. A basic perseverative tendency ('stickiness'), or choice repetition irrespective of the outcome produced, was likewise increased in rats after the 12-day SSRI regimen and decreased after single dose SSRI in humans and 5,7-DHT in rats. These common effects of serotonergic manipulations on rats and humans-identified via computational modelling-suggest an evolutionarily conserved role for serotonin in plasticity and behavioral flexibility and have clinical relevance transdiagnostically for neuropsychiatric disorders.

Indexed as

CitalopramSerotoninAnimalsHumansRatsReinforcement, PsychologyReversal LearningSelective Serotonin Reuptake InhibitorsCitalopramSelective Serotonin Reuptake InhibitorsSerotonin

Identifiers

PMID37914893
PMCPMC10789782
OpenAlexW4388125833

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.